PCH
LLY icon

PGIM Custom Harvest’s Eli Lilly LLY Stock Holding History

PGIM Custom Harvest’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.62M Sell
7,200
-288
-4% -$292K 0.1% 65
2025
Q4 		$8.05M Buy
7,488
+80
+1% +$76.5K 0.12% 58
2025
Q3 		$5.65M Buy
7,408
+686
+10% +$510K 0.09% 64
2025
Q2 		$5.24M Sell
6,722
-239
-3% -$186K 0.11% 56
2025
Q1 		$5.75M Buy
6,961
+1,899
+38% +$1.58M 0.14% 52
2024
Q4 		$3.91M Sell
5,062
-1,871
-27% -$1.55M 0.08% 67
2024
Q3 		$6.14M Buy
6,933
+624
+10% +$561K 0.12% 53
2024
Q2 		$5.71M Buy
6,309
+3,642
+137% +$2.91M 0.13% 53
2024
Q1 		$2.07M Sell
2,667
-9
-0.3% -$6.41K 0.05% 76
2023
Q4 		$1.56M Buy
2,676
+1,019
+61% +$595K 0.05% 84
2023
Q3 		$890K Buy
1,657
+283
+21% +$146K 0.03% 95
2023
Q2 		$644K Sell
1,374
-106
-7% -$44.5K 0.02% 105
2023
Q1 		$508K Sell
1,480
-1,091
-42% -$368K 0.02% 129
2022
Q4 		$941K Buy
+2,571
New +$912K 0.04% 99

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

PGIM Custom Harvest's LLY Position: Q1 2026 in Review

PGIM Custom Harvest reduced its Eli Lilly (LLY) stake by 3.8% in Q1 2026, selling an estimated $292K and leaving 7,200 shares worth $6.62M. The position accounts for 0.1% of the portfolio, ranked #65.

PGIM Custom Harvest first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.05M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • PGIM Custom Harvest held 7,200 shares of Eli Lilly worth $6.62M as of Q1 2026.
  • PGIM Custom Harvest sold 288 Eli Lilly shares in Q1 2026, an estimated $292K.
  • Eli Lilly made up 0.1% of PGIM Custom Harvest's portfolio in Q1 2026, its #65 holding.
  • PGIM Custom Harvest first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • PGIM Custom Harvest's Eli Lilly position peaked at $8.05M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on PGIM Custom Harvest's 13F filing for Q1 2026, filed 13 May 2026.